Exploring the Mechanism of Resveratrol in Reducing the Soft Tissue Damage of Osteoarthritis Based on Network Pharmacology and Experimental Pharmacology

<div>(a) Toll-like receptor signaling pathway adapted from KEGG (ID: hsa04620); (b) NF-kB signaling pathway adapted from KEGG (ID: hsa04064).</div>

Evidence-Based Complementary and Alternative Medicine

fig6

Figure 6

Figure 6: Exploring the Mechanism of Resveratrol in Reducing the Soft Tissue Damage of Osteoarthritis Based on Network Pharmacology and Experimental Pharmacology 

Figure 6 | Exploring the Mechanism of Resveratrol in Reducing the Soft Tissue Damage of Osteoarthritis Based on Network Pharmacology and Experimental Pharmacology 